Acurx Prescription pills announced plans to allocate up to $1 million payment of Bitcoin for its treasury reserves in a strategic pass to embrace BTC as a retailer of note.
The resolution licensed this day by the company’s board of administrators aligns with a growing pattern among companies searching for quite numerous financial suggestions amid Bitcoin’s rise as a mainstream asset.
Acurx CEO David P. Luci highlighted the appeal of Bitcoin as a treasury reserve asset in his commentary:
“As search data from for Bitcoin grows and Bitcoin becomes accredited as a essential and vital asset class, we own Bitcoin will attend as a solid treasury reserve asset for unneeded cash over the next 12 to 18 months. Its tiny present and inflation-resistant properties invent it a functional retailer of note.”
Luci particularly emphasised that this pass is solely a financial technique and isn’t going to affect the company’s ongoing drug pattern efforts.
Acurx’s resolution reflects the elevated technique adopted by MicroStrategy, which first added Bitcoin to its treasury in 2020, purchasing 21,454 BTC at a median note of $11,653 per coin. Since then, MicroStrategy has persevered to own Bitcoin, reaching a total of 331,200 BTC as of this week. The company’s stock is decided to rise by over 500% by 2024, demonstrating the success of its Bitcoin-centered plan.
The announcement by Acurx comes at a time when Bitcoin is trading the least bit-time highs and analysts are predicting extra positive aspects amid President-elect Donald Trump’s promises of a crypto-friendly regulatory atmosphere.
*Right here’s not investment advice.
